| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/15/2008 | US20080113948 2-(acetyloxy)-5-hydroxybenzenesulfonic acid, or 5-(acetyloxy)-2-hydroxybenzene-sulfonic acid, or 2,5-bis(acetyloxy)benzenesulfonic acid, or sultosilic acid for example; combination therapy |
| 05/15/2008 | US20080113947 2-(acetyloxy)-5-hydroxybenzenesulfonic acid, or 5-(acetyloxy)-2-hydroxybenzene-sulfonic acid, or 2,5-bis(acetyloxy)benzenesulfonic acid, or sultosilic acid for example; combination therapy |
| 05/15/2008 | US20080113946 N-aryl-5,7-dihydrofuro[3,4-d]pyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/15/2008 | US20080113945 Compositions and methods for inhibiting cytochrome p450 |
| 05/15/2008 | US20080113944 Novel Indole Derivatives |
| 05/15/2008 | US20080113943 4-phenyl-N-substituted azetidin-2-ones; selective prostaglandin EP2 agonists; glaucoma or ocular hypertension |
| 05/15/2008 | US20080113942 Phosphorylcholine Group-Containing Compound and Method for Producing Same |
| 05/15/2008 | US20080113941 4-O esters of podophyllotoxin and 4'-demethylepipodophyllotoxin 4'-phosphonic acid or phosphonate derivatives; anticancer agents; type II DNA topoisomerase (topoisomerase II) inhibitors |
| 05/15/2008 | US20080113939 N-geranylgalacturonamide; anticarcinogenic, antitumor agent |
| 05/15/2008 | US20080113938 Accelerator for mineral absorption and use thereof |
| 05/15/2008 | US20080113937 Agent For Preventing And Ameliorating Obesity |
| 05/15/2008 | US20080113936 Process for the preparation of adsorbates of valsartan and/or its solvates or hydrates |
| 05/15/2008 | US20080113935 dipalmitoyl or dimyristoyl phosphatidylethanolamine is conjugated with a monomer, dimer, oligomer or polymer selected from alginates, polygelin, carboxymethyl cellulose, hydroxyethylstarch, chondrotin sulfate etc directly or via a spacer; for treatment of retinopathy, glaucoma and other vision defects |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113931 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, substantially complementary to at least part of an mRNA transcript of an Aha gene; cancer or cystic fibrosis |
| 05/15/2008 | US20080113930 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, complementary to at least a part of the PCSK9 gene; antihyperlipemia agent |
| 05/15/2008 | US20080113928 Modified Cea/B7 Vector |
| 05/15/2008 | US20080113927 Indolopyrrolocarbazole derivatives and anti-tumor agent |
| 05/15/2008 | US20080113926 9A-Carbamoyl-Y-Aminopropyl- And 9A-Thiocabamoyl-Y-Aminopropyl-Azalides With Antimalarial Activity |
| 05/15/2008 | US20080113925 Compositions and Methods for Increasing Telomerase Activity |
| 05/15/2008 | US20080113924 Neuramindase Inhibitor |
| 05/15/2008 | US20080113923 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent |
| 05/15/2008 | US20080113922 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents |
| 05/15/2008 | US20080113921 Use of a Compound Comprising D-Mannoheptulose and/or Perseitol for Treating and Preventing Innate Immunity Modification Diseases |
| 05/15/2008 | US20080113919 prenylation enzyme inhibitors such as 5,9,13-trimethyl-2-nitrotetradeca-2,8,12-triene, used as anticarcinogenic or antitumor agents |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113902 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113351 Nucleotide sequence for prevention and treatment of cell proliferative disorders; antitumor agents |
| 05/15/2008 | US20080113346 Using allelic variation in uncoupling gene (UCP2/UCP3)sequences as rheumatoid arthritis diagnostic |
| 05/15/2008 | US20080113343 Method of Inhibiting Prostate Cancer Cell Proliferation |
| 05/15/2008 | US20080113341 Fluorinated resorufin compounds and their application |
| 05/15/2008 | US20080113340 Diagnosis and treatment of cervical cancer |
| 05/15/2008 | US20080113046 Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients |
| 05/15/2008 | US20080113045 plant extracts from radish seeds, celery seeds, black seeds and ginger rhizomes, used for increasing semen, intensifying motility, adjusting the volume of the ejaculate or the liquefaction time of the ejaculate; treatment of sexual disorders |
| 05/15/2008 | US20080113039 synergistic mixture of 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline and a platinum antitumor agent selected from cisplatin, carboplatin or oxaliplatin, for the treatment of cancers; angiogenesis inhibitors and vascular permeability reducing effect in mammals |
| 05/15/2008 | US20080113037 Topical Compositions Comprising Polyhydroxy Acids and/or Lactones for Improved Cutaneous Effects of Oxidative Therapeutic Drugs |
| 05/15/2008 | US20080113035 medical equipment, drug delivery devices or implants containing antimitotic agents such as taxol or diterpenes, used for treating inflammatory diseases such as psoriasis or multiple sclerosis |
| 05/15/2008 | US20080113032 a nonaqueous mixture of topical anesthetics, solubilizers, homopolymers, copolymers and plant extract oils, used for relieving pain on the skin or hair follicles prior to hair treatment such as braiding, electrolysis, plugging or removal |
| 05/15/2008 | US20080113030 Sustained release tamsulosin formulations |
| 05/15/2008 | US20080113028 Novel Block Copolymer, Micelle Preparation, And Anticancer Agent Containing The Same As Active Ingredient |
| 05/15/2008 | US20080113025 Compositions comprising nanoparticulate naproxen and controlled release hydrocodone |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113023 comprising a first layer containing 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-ylmethyl]-biphenyl-2-carboxylic acid dispersed in dissolving matrices and a second layer containing hydrochlorothiazide in a disintegrating tablet matrix |
| 05/15/2008 | US20080113022 non-film-coated tablets comprising a mixture of 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride, microcrystalline cellulose, lubricants, colloidal silica and lactose, having stability |
| 05/15/2008 | US20080113021 particles comprising ibuprofen and a taste masking water soluble acid and matrice comprising a second water soluble acid; immediate release tablet capable of being chewed or disintegrated in the mouth |
| 05/15/2008 | US20080113020 Solid pharmaceutical composition comprising telithromycin |
| 05/15/2008 | US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances |
| 05/15/2008 | US20080113016 Method for Prevention or Treatment of Inflammatory Disease |
| 05/15/2008 | US20080113015 drug delivery devices comprising capsules containing drugs distributed within an aqueous phase in the interior of the capsule |
| 05/15/2008 | US20080113014 Method for Screening for Compounds Safe for Gastric Mucosa |
| 05/15/2008 | US20080113012 Method for using transdermal system with fentanyl |
| 05/15/2008 | US20080113010 Nonaqueous Preparation for Percutaneous Absorption Containing Nonsteroidal Anti-Inflammatory Analgesic |
| 05/15/2008 | US20080113003 Animal feed with sinapic acid; beneficial bacteria, Bifidocacterium, propionibacterium in the gastrointestinal tract increase in numbers while detrimental bacteria, Escherichia and Salmonella |
| 05/15/2008 | US20080113000 Overcoating a medical insert with active materials to prevent infections; coating releases a chemotherapeutic agent such as 5-fluorouracil which reduces, inhibits, or prevents the growth or transmission of foreign organisms |
| 05/15/2008 | US20080112997 Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo |
| 05/15/2008 | US20080112995 Implantable Bioreactors and Uses Thereof |
| 05/15/2008 | US20080112994 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
| 05/15/2008 | US20080112991 Method of enhancing skin absorption of nutrients and active agents |
| 05/15/2008 | US20080112986 Controlled release sterile injectable aripiprazole formulation and method |
| 05/15/2008 | US20080112985 Controlled release sterile injectable aripiprazole formulation and method |
| 05/15/2008 | US20080112978 Method For Treatment of Hiv Infection |
| 05/15/2008 | US20080112977 Supertype Epitopes, Oligonucleotides Coding The Same Which Induce Effective Ctl Response Against Hcv And The Use Thereof |
| 05/15/2008 | US20080112968 Nicotinamide compositions for treatment of skin diseases and disorders |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112955 Method and composition for preventing pain in sickle cell patients |
| 05/15/2008 | US20080112947 I kappa b kinase complex as a target for the treatment of huntington's disease |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | US20080112945 Mixture comprising dexamethasone, vitamin B, metronidazole, berberine, etamsylate, gentamicin, chymotrypsin, methylene blue trihydrate and sodium bicarbonate for improving effectiveness of local anesthetics |
| 05/15/2008 | US20080112941 Using live bacterial cultures to treat or reduce incidence of lactose intolerance in mammals |
| 05/15/2008 | US20080112932 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112931 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 05/15/2008 | US20080112926 Preparing chimeric polypeptide comprising glycosaminoglycan-binding proteins (GAG) for use in prevention and treatment of skin, nervous system and inflammatory disorders |
| 05/15/2008 | US20080112923 Ocular therapy using alpha-2 adrenergic receptor anterior compounds having enhanced clearance rates |
| 05/15/2008 | US20080112922 Combining an agonist with a liquid carrier or a polymer to administer to an eye, and determining the vitreous half-life and clearance of the drug; sustained drug delivery affecting the anterior or anterior/posterior eye segment; neuroprotection;antiischemic agents; glaucoma; vitreal half-life |
| 05/15/2008 | US20080112921 Parenterally administering a combination of a abhesive nonionic polymer and a magnesium salt to a site of injury, e.g. polyoxyethylene glycol and magnesium chloride; blocking agents for for cellular adhesion and for methyl-D-asparate receptors; antiinflammatory agents; autoimmune diseases |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | US20080112918 Method for treating gout and binding uric acid |
| 05/15/2008 | US20080112917 Sphingolipids' Polyalkylamines Conjugates |
| 05/15/2008 | US20080112915 Skin disorders; metabolic disorders; gene therapy; biocompatability |
| 05/15/2008 | US20080112904 Sunscreen Compositions And Methods Of Use |
| 05/15/2008 | US20080112899 Carboxamides and Their Use |
| 05/15/2008 | US20080112895 Cannabinoids in buffer/cosolvent such as ethanol, propylene glycol and/or polyethylene glycol; ophthalmology |
| 05/15/2008 | US20080112892 X-Ray Visible Drug Delivery Device |
| 05/15/2008 | US20080112891 Contrast agents; imaging |
| 05/15/2008 | US20080112889 Histone deacetylase 8 ( HDAC8); treating T-cell lymphoma by administering a population of autologous T-cells that have been exposed to a selective HDAC8 inhibitor composition ex vivo |
| 05/15/2008 | US20080112888 Igfbp2 biomarker |
| 05/15/2008 | US20080109989 Stacking wall panel system and methods of installation and use |
| 05/15/2008 | DE4418796C5 Oral anwendbare und gegen Plaque und Gingivitis wirkende Zusammensetzungen An oral and acting against plaque and gingivitis compositions |
| 05/15/2008 | DE202006020224U1 Pharmazeutische Zusammensetzung Pharmaceutical composition |
| 05/15/2008 | DE112006001853T5 Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten Pharmaceutical compositions containing Clopidogrel bisulfate |
| 05/15/2008 | DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer |
| 05/15/2008 | DE102006053637A1 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted with fluorine 1,4-benzothiepine 1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053636A1 Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New-substituted 1,4-cyclohexyl-1,1-dioxide derivatives benzothiepine, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053635A1 Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New substituted benzyl 1,4-benzothiepine-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
| 05/15/2008 | DE102006053500A1 Antimicrobial compounds for controlling selective microorganisms such as gram-positive bacteria, particularly coryneform bacteria, has general formula |
| 05/15/2008 | DE102006053385A1 Enterococcus faecalis- und/oder Enterococcus faecium-Antigen Enterococcus faecalis and / or Enterococcus faecium antigen |
| 05/15/2008 | CA2705457A1 Novel arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| 05/15/2008 | CA2672956A1 Calcium receptor modulating agents |